BackClene- Warrants (30/12/2025) Overview

Clene- Warrants (30/12/2025) Total Liabilities

Latest total liabilities for CLNNW: $40M.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$40.47M
33.62% YoYΔ $10.18M vs prior year quarter

Peer average

Loading

Clene- Warrants (30/12/2025) Total Liabilities History

Loading

Clene- Warrants (30/12/2025) vs. peers: Total Liabilities Comparison

Loading

Clene- Warrants (30/12/2025) Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Clene- Warrants (30/12/2025) (CLNNW) FAQ

Clene- Warrants (30/12/2025)'s total liabilities stands at $40M as of March 2026. That compares with $30M in the prior-year period — up 33.6% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Clene- Warrants (30/12/2025) reported $40M in total liabilities versus $30M a year earlier — a 33.6% year-over-year increase. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $30M in the prior-year period — up 33.6% year over year. Sustained growth in total liabilities can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Clene- Warrants (30/12/2025)'s total liabilities evolved across reporting periods, while the comparison chart places CLNNW next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, total liabilities is commonly used to spot outliers. Clene- Warrants (30/12/2025)'s reading of $40M is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.